| P50 | author | Shamaila Waseem | Q87417014 |
| P2093 | author name string | Peter V Draganov | |
| | Baharak Moshiree | |
| P2860 | cites work | 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake | Q24538184 |
| | Electrogastrography: a document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task Force | Q28189254 |
| | Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics | Q30451608 |
| | The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. | Q30467463 |
| | The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis | Q30470483 |
| | The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. | Q30470587 |
| | Sildenafil inhibits gastroduodenal motility | Q31811097 |
| | Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice | Q31847993 |
| | Esophagitis and gastroduodenal disorders associated with diabetic gastroparesis | Q69264652 |
| | Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects | Q81528828 |
| | Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis | Q81810853 |
| | New motilin agonists: a long and winding road | Q82050277 |
| | Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy | Q70044293 |
| | Gastric emptying of solid radiopaque markers: studies in healthy subjects and diabetic patients | Q70587533 |
| | Clinical value of duodenojejunal manometry. Its usefulness in diagnosis and management of patients with gastrointestinal symptoms | Q71068575 |
| | Effect of dexloxiglumide and spiroglumide, two new CCK-receptor antagonists, on gastric emptying and secretion in the rat: evaluation of their receptor selectivity in vivo | Q71498439 |
| | [13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function | Q71557602 |
| | Gastrokinetic effects of erythromycin: myogenic and neurogenic mechanisms of action in rabbit stomach | Q71776039 |
| | Effect of D2‐dopamine receptor antagonist levosulpiride on diabetic cholecystoparesis : a double‐blind crossover study | Q71860089 |
| | Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients | Q72550810 |
| | Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins | Q72590080 |
| | Erythromycin enhances gastric emptying in patients with gastroparesis after vagotomy and antrectomy | Q72795388 |
| | Gastric electrical stimulation in intractable symptomatic gastroparesis | Q73014612 |
| | Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis | Q73033732 |
| | Prepulsid withdrawn from UK & US markets | Q73143160 |
| | Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome | Q73509709 |
| | Motilin and OHM-11526 activate a calcium current in human and canine jejunal circular smooth muscle | Q73644849 |
| | Gastric electrical stimulation for medically refractory gastroparesis | Q73735575 |
| | A new endoscopic technique for the removal of gastric phytobezoars | Q74253574 |
| | Assessment of gastric motor function during the emptying of solid and liquid meals in humans by MRI | Q74465194 |
| | Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis | Q74836731 |
| | Neural injury, repair, and adaptation in the GI tract. IV. Pathophysiology of GI motility related to interstitial cells of Cajal | Q77181177 |
| | Role of impaired gastric accommodation to a meal in functional dyspepsia | Q77620673 |
| | Hyperglycaemia attenuates erythromycin-induced acceleration of solid-phase gastric emptying in idiopathic and diabetic gastroparesis | Q77872392 |
| | Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients | Q78158034 |
| | Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report | Q78419066 |
| | Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms | Q80057913 |
| | Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients | Q80109502 |
| | Botulinum toxin A for the treatment of delayed gastric emptying | Q80173091 |
| | Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis | Q81458634 |
| | Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one center's experience | Q33541502 |
| | Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial | Q34056901 |
| | AGA technical review on nausea and vomiting | Q34157063 |
| | Diabetic autonomic neuropathy | Q34193010 |
| | Oral erythromycin and the risk of sudden death from cardiac causes | Q34346855 |
| | A placebo-controlled trial of itopride in functional dyspepsia | Q34496974 |
| | Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis | Q34508541 |
| | Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine | Q34581268 |
| | Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study | Q34693031 |
| | Chronic metoclopramide therapy for diabetic gastroparesis | Q35035103 |
| | Diabetic gastropathy and prokinetics | Q35068007 |
| | Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. | Q35126913 |
| | Nutrition therapy for diabetic gastroparesis | Q35219428 |
| | Scintigraphic validation of a magnetic resonance imaging method to study gastric emptying of a solid meal in humans | Q35565536 |
| | A systematic review of surgical therapy for gastroparesis | Q35565623 |
| | Real time high resolution magnetic resonance imaging for the assessment of gastric motility disorders | Q35596831 |
| | Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. | Q35598031 |
| | Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting | Q35693273 |
| | Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation | Q35757449 |
| | American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis | Q35936586 |
| | Treatment of gastroparesis: a multidisciplinary clinical review | Q36428532 |
| | Gastroparesis: clinical update | Q36476747 |
| | Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis | Q36630504 |
| | Tricyclic antidepressants for chronic vomiting in diabetic patients | Q36695351 |
| | Ultrasound of the stomach--the EUROSON lecture 2006. | Q36737205 |
| | Agonist effect of erythromycin and its analogues on motilin receptors. A new family of prokinetics? Clinical interest | Q36758370 |
| | Gastroparesis | Q36775502 |
| | Gastroparesis: symptoms, evaluation, and treatment | Q36976543 |
| | Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine | Q37009041 |
| | Review article: gastroparesis | Q37076537 |
| | Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic | Q40248870 |
| | Metoclopramide therapy in patients with delayed gastric emptying: a randomized, double-blind study | Q41105875 |
| | Towards a less costly but accurate test of gastric emptying and small bowel transit | Q41152382 |
| | Abnormal intestinal motility in diabetics with the gastroparesis syndrome | Q41573655 |
| | Measurement of gastric emptying by real-time ultrasound | Q42112488 |
| | Gastric emptying improvement after simultaneous segmental pancreas and kidney transplantation | Q42122820 |
| | Q-T interval prolongation and ventricular fibrillation with i.v. domperidone | Q42220636 |
| | Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. | Q42460630 |
| | The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders | Q42558135 |
| | Prokinetics in patients with gastroparesis: a systematic analysis | Q42609247 |
| | Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis | Q43547595 |
| | Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis | Q43692745 |
| | Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects | Q43782284 |
| | Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K(+) channel | Q43803831 |
| | Reversal of pyrogallol-induced delay in gastric emptying in rats by ginger (Zingiber officinale). | Q43903825 |
| | Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying | Q43923612 |
| | Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes | Q44138918 |
| | Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans | Q44352730 |
| | Ginger reduces hyperglycemia-evoked gastric dysrhythmias in healthy humans: possible role of endogenous prostaglandins | Q44611093 |
| | Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans | Q44797399 |
| | Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial | Q44832664 |
| | The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus | Q45081231 |
| | Influence of sildenafil on gastric sensorimotor function in humans | Q45099367 |
| | Selective reversal of hyperglycemia-evoked gastric myoelectric dysrhythmias by nitrergic stimulation in healthy humans | Q45115209 |
| | Clinical observation on acupuncture treatment in 35 cases of diabetic gastroparesis. | Q45128592 |
| | Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers? | Q45713757 |
| | Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia | Q46284007 |
| | Azithromycin-induced torsade de pointes | Q46857435 |
| | Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow-up | Q47708905 |
| | Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis | Q47710455 |
| | Intragastric distribution and gastric emptying assessed by three-dimensional ultrasonography | Q49110730 |
| | Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis | Q50147994 |
| | Mechanisms of high-frequency electrical stimulation of the stomach in gastroparetic patients. | Q50885203 |
| | Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors. | Q50988726 |
| | Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. | Q51300549 |
| | Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery. | Q51455510 |
| | A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. | Q51478176 |
| | Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis. | Q51530922 |
| | Development of a test to measure gastric accommodation in humans. | Q51559317 |
| | Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. | Q51565272 |
| | Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats. | Q51602963 |
| | Pyloric dysfunction in diabetics with recurrent nausea and vomiting. | Q51633620 |
| | Measurement of gastric emptying time by real-time ultrasonography. | Q51636882 |
| | Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. | Q51659975 |
| | Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. | Q52395160 |
| | Pain: the overlooked symptom in gastroparesis. | Q52911384 |
| | Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study. | Q53607459 |
| | Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life. | Q53665759 |
| | Measurement of gastrointestinal motility in the GI laboratory. | Q53946989 |
| | Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult | Q57010174 |
| | Clomipramine and mianserin in chronic idiopathic pain syndrome | Q57025223 |
| | Dyspeptic Symptoms in Children: The Result of a Constipation-Induced Cologastric Brake? | Q62051594 |
| | Measurements of gastric emptying of low- and high-nutrient liquids using 3D ultrasonography and scintigraphy in healthy subjects | Q62479524 |
| | The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals | Q63351121 |
| | Prokinetic effect of AS-4370 on gastric emptying in healthy adults | Q67878380 |
| | Gastric emptying and subjective symptoms of nausea: lack of effects of a 5-hydroxytryptamine-3 antagonist ondansetron on gastric emptying in patients with gastric stasis syndrome | Q68434433 |
| | Measurement of gastric emptying rate in humans by real-time ultrasound | Q68861151 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gastroparesis | Q943897 |
| P304 | page(s) | 25-37 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Gastroparesis: current diagnostic challenges and management considerations | |
| P478 | volume | 15 | |